Jaceidin Suppresses Melanoma Metastasis by Modulating ERK , JNK Pathways and Extracellular Matrix Degradation Proteins
Journal of Cellular and Molecular Medicine · 2026-02 · 30 (4)
DOI: 10.1111/jcmm.71068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 23.02.2026. Verfasst von Mu-Kuei Shieu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Changhua Christian Hospital, Changhua, Taiwan. Hauptthemen laut MEDLINE: Melanoma, JNK Mitogen-Activated Protein Kinases, MAP Kinase Signaling System, Extracellular Matrix Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changhua Christian Hospital.
Abstract (Originalsprache)
Metastatic melanoma, marked by its poor prognosis and frequent recurrence, is a particularly aggressive skin cancer. Jaceidin, a compound derived from flavonoids abundant in common fruits and vegetables, has attracted interest for its potential anti‐cancer properties. Nevertheless, the specific effects of jaceidin on melanoma cells remained unclear before this study. Here, we examined the impact of jaceidin on two metastatic melanoma cell lines, HMY‐1 and A2058. Our results demonstrate that jaceidin exerts a significant anti‐metastatic effect against both cell lines. This inhibitory action involved modulating the phosphorylation of extracellular signal‐regulated kinase and c‐Jun N‐terminal kinase, as well as suppressing proteins associated with epithelial‐mesenchymal transition. Furthermore, jaceidin reduced the expression of extracellular matrix degradation proteins MMP‐2 and cathepsins A. These compelling findings suggest that jaceidin warrants further investigation as a potential therapeutic agent for melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Changhua Christian Hospital, Changhua, Taiwan.
- Oral Cancer Research Center, Changhua Christian Hospital, Changhua, Taiwan.
- Department of Pharmacy, Changhua Christian Hospital, Changhua, Taiwan.
- Graduate Institute of Clinical Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- Doctoral Program in Tissue Engineering and Regenerative Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan.
ORCID-Profile: Ming-Ju Hsieh
Förderung
- Changhua Christian Hospital
Zitieren
APA
Shieu, M. K., Yang, H. J., Lin, C. C., Kao, M. Y., Ho, H. Y., Lo, Y. S., Chuang, Y. C., Yang, Y. T., & Hsieh, M. J. (2026). Jaceidin Suppresses Melanoma Metastasis by Modulating ERK , JNK Pathways and Extracellular Matrix Degradation Proteins. Journal of Cellular and Molecular Medicine, 30(4). https://doi.org/10.1111/jcmm.71068
Vancouver
Shieu MK, Yang HJ, Lin CC, Kao MY, Ho HY, Lo YS, et al. Jaceidin Suppresses Melanoma Metastasis by Modulating ERK , JNK Pathways and Extracellular Matrix Degradation Proteins. Journal of Cellular and Molecular Medicine. 2026;30(4). doi:10.1111/jcmm.71068
BibTeX
@article{Shieu2026,
author = {Shieu, Mu-Kuei and Yang, Hui-Ju and Lin, Chia-Chieh and Kao, Min-Yun and Ho, Hsin-Yu and Lo, Yu-Sheng and Chuang, Yi-Ching and Yang, Yuan-Ting and Hsieh, Ming-Ju},
title = {Jaceidin Suppresses Melanoma Metastasis by Modulating ERK , JNK Pathways and Extracellular Matrix Degradation Proteins},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {4},
doi = {10.1111/jcmm.71068}
}
EUVIMED